Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 06-2013 | 12-2012 | 06-2012 | 12-2011 | |
| Sales | 100 | 0 | 0 | 0 | 200 |
| Gross Profit | 0 | N/A | 0 | N/A | 200 |
| Operating Expenses | 5,909 | 4,651 | 3,154 | 0 | 1,650 |
| Operating Income | -5,809 | -4,651 | -3,154 | N/A | -1,450 |
| Interest Expense | 0 | 119 | 119 | 0 | 30 |
| Other Income | 0 | -1,353 | -2,850 | 0 | -40 |
| Pre-tax Income | -5,809 | -6,123 | -6,123 | 0 | -1,520 |
| Net Income Continuous | -6,409 | -6,123 | -5,066 | N/A | -6,419 |
| Net Income | $-9,225 | $-6,123 | $-6,123 | $N/A | $-1,520 |
| EPS Basic Total Ops | N/A | -4,088.00 | -6,400.00 | N/A | -11,200.00 |
| EPS Basic Continuous Ops | N/A | -3,585.68 | -4,605.46 | N/A | -7,132.22 |
| EPS Diluted Total Ops | N/A | -4,088.00 | -6,400.00 | N/A | -11,200.00 |
| EPS Diluted Continuous Ops | N/A | -3,585.68 | -4,605.46 | N/A | -7,132.22 |
| EBITDA(a) | $-5,659 | $-4,357 | $-3,024 | $N/A | $-1,340 |